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Abstract
Background: The Cochrane Neonatal Review Group (CNRG) has achieved a lot with limited
resources in producing high quality systematic reviews to assist clinicians in evidence-based
decision-making. A formal assessment of published CNRG systematic reviews has not been
undertaken; we sought to provide a comprehensive assessment of the quality of systematic reviews
(both methodologic and reporting quality) published in CNRG.
Methods: We selected a random sample of published CNRG systematic reviews. Items of the
QUOROM statement were utilized to assess quality of reporting, while items and total scores of
the Oxman-Guyatt Overview Quality Assessment Questionnaire (OQAQ) were used to assess
methodologic quality. Two reviewers independently extracted data and assessed quality. A Student
t-test was used to compare quality scores pre- and post-publication of the QUOROM statement.
Results: Sixty-one systematic reviews were assessed. Overall, the included reviews had good
quality with minor flaws based on OQAQ total scores (mean, 4.5 [0.9]; 95% CI, 4.27–4.77).
However, room for improvement was noted in some areas, such as the title, abstract reporting, a
priori plan for heterogeneity assessment and how to handle heterogeneity in case it exists, and
assessment of publication bias. In addition, reporting of agreement among reviewers,
documentation of trials flow, and discussion of possible biases were addressed in the review
process. Reviews published post the QUOROM statement had a significantly higher quality scores.
Conclusion: The systematic reviews published in the CNRG are generally of good quality with
minor flaws. However, efforts should be made to improve the quality of reports. Readers must
continue to assess the quality of published reports on an individual basis prior to implementing the
recommendations.
Background
As new clinical evidence is accumulating at a phenomenal
rate, staying up-to-date with the current state of knowl-
edge can be a challenging task for health care providers. It
has been estimated that a physician would need to read
17–20 journal articles a day to keep up to date with his
particular area of interest[1,2]. This is one of many rea-
sons why systematic reviews and meta-analyses have been
introduced as a solution to synthesize and summarize evi-
dence of primary studies on a given topic. Meta-analyses
of high quality, randomized, controlled trials (RCT) are
considered to be the highest level of evidence in the hier-
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archy of evidence-based medicine for preventive and ther-
apeutic interventions [3,4].
The Cochrane Collaboration (CC), founded in 1993, is a
well-recognized international organization. It aims to
help health care professionals make an informed deci-
sions about health care by preparing, maintaining, and
promoting the accessibility of systematic reviews on the
effects of health care interventions [5,6]. The Cochrane
Neonatal Review Group (CNRG), dedicated to improving
outcomes of newborn infants, is one of the 51 collabora-
tive groups registered with the CC, and has achieved a
considerable amount with limited resources in synthesiz-
ing and providing the highest quality of evidence to neo-
natal health care providers [7]. Members of the CNRG
prepare reviews of the results of RCT's of intervention for
treatment and prevention of disease in newborn infants
[8]. In preparing their reviews, reviewers follow systematic
methods summarized in the Cochrane Reviewer's Hand-
book and summarized in a checklist developed specifi-
cally for the neonatal reviews by the editors of the
group[9]. A protocol that outlines the specific scientific
objectives and methods of the review must be accepted
prior to the start of the review process. All protocols and
reviews are published four times a year in the neonatal
module of the Cochrane Library and on a National Insti-
tute of Child Health and Human Development (NICHD)
website for Cochrane neonatal reviews. The number of
reviews has steadily increased over the last few years with
more than 200 completed reviews currently published.
Compared to systematic reviews published in paper-based
journals, Cochrane reviews appear to have greater meth-
odologic rigor and include elements that make them less
prone to bias, such as description of inclusion and exclu-
sion criteria, and formal assessment of the trial's quality
[10]. In addition, the reviews are more frequently
updated[10]. However, Cochrane reviews are not
immune to methodologic flaws and the room for contin-
ual assessment and improvement in quality still
exists[11]. Ensuring publication of systematic reviews
with the highest possible quality will likely ensure that the
results are less likely influenced by bias, therefore ena-
bling clinicians to be more confident in implementing
different interventions in their practice [12].
As for any research project, assessment of the quality of
systematic reviews is essential to judge whether the recom-
mendation warrants a change in practice. This can be
done through assessment of both methodologic quality
(how well the systematic review was conducted) and
reporting quality (how well the methodology and find-
ings are presented[11]. The most commonly used tools to
assess quality of systematic reviews are the Quality of
Reporting of Meta-analysis statement (QUOROM state-
ment) and the Overview Quality Assessment Question-
naire-OQAQ[13,14].
The current study was performed to provide a comprehen-
sive assessment of the quality of systematic reviews (both
methodologic and reporting quality) published in CNRG
and to assess whether the publication of the Quality of
Reporting of Meta-analysis statement (QUOROM) pub-
lished in 1999 is associated with an improvement of in
the quality of the reviews under study.
Methods
Sample Selection
Through contact with the CNRG coordinator (Ms. Diane
Haughton), we obtained all titles and first author names
of all neonatal systematic reviews published in the Data-
base of Systematic Reviews of the Cochrane Library (Issue
4, 2005). We then selected 61 reviews arbitrarily (approx-
imately one-third of a total of 210 reviews) by a simple
random sampling using Microsoft Excel 2003 random
function (Microsoft Corporation, Redmond, WA, USA;
table 1; [15].
Quality Assessment Instruments
Based on a previous extensive review of published scales
and checklists available for quality assessment of system-
Table 1: Characteristics of the included CNRG systematic 
reviews.
Number of included reviews 61
Publication year
1997 3 (5)
1998 8 (13)
1999 6 (10)
2000 2 (3)
2001 6 (10)
2002 9 (15)
2003 11 (18)
2004 10 (16)
2005 6 (10)
Subspecialty *
Cardiac 6 (10)
Respiratory 19 (31)
Neurology 1 (2)
Nutrition 14 (23)
Pain 1 (2)
Developmental care 2 (3)
Environmental 2(3)
Infectious 7 (11)
Other 9 (15)
Type *
Therapy 61 (100)
Post-QUOROM * 44 (82)
No. of included studies** 3 (1,6)
* Numbers (percentages)
** Median + inter-quartile rangesBMC Pediatrics 2009, 9:38 http://www.biomedcentral.com/1471-2431/9/38
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atic reviews[11], the two instruments selected were meth-
odologic tools that were rigorously developed by Oxman
and Guyatt (Overview Quality Assessment Questionnaire
[OQAQ][14]; and the Quality of Reporting of Meta-anal-
ysis (QUOROM) statement, published in November
1999[13].
Quality of Reporting of Meta-analysis (QUOROM) 
statement[13]
This tool was developed to assist the authors of systematic
reviews in proper reporting. It consists of a checklist (18
items subdivided to cover; abstract, introduction, meth-
ods, results, and discussion) and a flow diagram (table 2).
Since some of the items encompass sub-items, we evalu-
ated each sub-item as a separate entity in this study.
Overview Quality Assessment Questionnaire (OQAQ)[14]
This tool was designed to evaluate adherence of review
articles to scientific principles. It consists of 10 questions
(table 3). The first 9 questions address the 5 methodologic
aspects of systematic reviews including search strategy,
study selection, validity assessment, data analysis, and
inferences. Each of these questions was answered as fol-
lows: "yes,", "partially/can't tell,", or "no." Based on
response to the 9 questions, the overall scientific quality
of the review article (question 10) was graded on a 7-point
scale according to the developer's instructions. The review
was considered to have extensive flaws if it received a score
of 1, major flaws if it received a score of 3, minor flaws if
it received a score of 5, and minimal flaws if it received a
score of 7[14]. The operating characteristics have been val-
idated; including inter-rater reliability, face validity, and
construct validity[16].
Data Extraction
Two reviewers (KA and MA) reviewed the full texts of all
included reviews and extracted data independently in a
database developed using Microsoft Access 2003 (Micro-
soft Corporation). Both reviewers have abstracted and
analyzed the data independently. Disagreement among
reviewers was resolved through consensus or by consult-
ing a third expert adjudicator.
In addition to the items in the OQAQ and QUOROM
statement, the review's demographic data were collected,
including: 1) the last name of the 1st author, 2) the sub-
specialty, 3) the epidemiologic affiliation of the 1st author
(whether he/she is qualified with a degree in epidemiol-
ogy or research methodology), and 4) the number of
included studies. Stratification based on relation to the
QUOROM statement publication date was entertained to
assess any potential effect of the QUOROM statement on
overall quality of included reviews; however, we found
that most reviews published prior to the QUOROM state-
ment publication were updated at a later stage (we
assessed the most recent version of the review).
Pilot testing
To enhance the reviewer's inter-rater agreement, we evalu-
ated 5 reviews (not included in the study sample) as a
pilot testing of the database prior to starting the data
abstraction process. Proper scoring of each item in the
database was discussed in detail.
Analysis
The primary analysis of our data was descriptive. The pro-
portion of reports that met each criterion was determined
and tabulated. Data on each item is presented as counts
and percentages. To determine whether the publication of
the QUOROM statement was associated with an improve-
ment of quality of published CNRG reviews, we compared
the mean and standard deviation of the overall scientific
quality scores (question 10 in OQAQ) of each pre- and
post-QUOROM groups using a two sample Student t-test
with Minitab software version 14[15]. Since the number
of reviews exceeded 30, and the data were normally dis-
tributed, a central limit theorem was assumed[15].
Results
Sample Demographics
Sixty-one CNRG systematic reviews were evaluated in our
study. Table 1 summarizes the demographic data of the
included reviews. All reviews in the CNRG addressed
interventions of a therapeutic nature. The distribution of
topics strongly favored respiratory (31%) and nutritional
(23%) interventions. The majority of the reviews (82%)
were published after the publication of the QUOROM
statement. The median number and inter-quartile ranges
of the included trials in each review were 3 (1, 6). Eight
reviews (13%) included no studies; therefore, assessment
of some elements in the results section of the reviews was
unfeasible. This explains the discrepant total numbers
that appear in table 2.
Reporting Quality (QUOROM statement elements)
Reports of various sub-items of the QUOROM statement
are presented in table 2. Reports ranged from 0–100%.
Although all reviews included in the CNRG had the word
"review" typed between brackets at the end of the title,
none of the titles identified the study as a systematic
review or a meta-analysis.
Almost all the CNRG review's abstracts were structured,
stated objectives, reported data sources, specified selec-
tion criteria adequately, and ended with a conclusion that
summarized the review's main findings. On the other
hand, important abstract elements of the review's meth-
ods (validity assessment, data abstraction, and data syn-
thesis details) and results (mainly characteristics of
included studies) were inadequately reported.
As per reporting standards in the Cochrane collaboration,
all reviews reported their search terms, databasesBMC Pediatrics 2009, 9:38 http://www.biomedcentral.com/1471-2431/9/38
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Table 2: Scores of included CNRG systematic reviews based on elements of the QUOROM statement.
QUOROM statement item * Yes No Partially/
Unclear
1. Title identified as meta-analysis or SR 0 (0) 61 (100)
Abstract
2. Structured format used 61 (100) 0 (0)
3. Objectives stated 37 (61) 2 (3) 22 (36)
4. Data sources reported 61 (100) 0 (0)
5. Review methods reported
Selection criteria 61 (100) 0 (0)
Validity assessment 4 (7) 57 (93)
Data abstraction 7 (11) 54 (89)
Study characteristics 1 (2) 60 (98)
Data synthesis 36 (59) 25 (41)
6. Results
Characteristics of studies 6 (11) 47 (89)
Quantitative findings 45 (85) 8 (15)
Subgroup 5 (9) 48 (91)
7. Conclusion 61 (100) 0 (0)
8. Introduction 61 (100) 0 (0)
Methods
9. Searching
Search Terms 61 (100) 0 (0)
Sources
Electronic Databases 61 (100) 0 (0)
MEDLINE 61 (100) 0 (0)
EMBASE 32 (52) 29 (48)
CENTRAL 52 (85) 9 (15)
CINAHL 26 (43) 35 (57)
Others 33 (54) 28 (46)
Online Registry of Studies 9 (15) 52 (85)
Personal Files 8 (13) 53 (87)
Citations List 53 (87) 8 (13)
Hand Search of Journals 21 (34) 40 (66)
Proceedings 47 (77) 14 (23)
Authors Contacts 10 (16) 51 (84)
Experts Contact 26 (43) 35 (57)
Manufacturers 2 (3) 59 (97)
Restrictions
Year 2 (3) 58 (95) 1 (2)
Publication Status 5 (8) 21 (35) 35 (57)
Language 2 (3) 38 (62) 21 (34)
10. Selection Criteria 61 (100) 0 (0)
11. Validity Assessment 48 (79) 13 (21)
12. Data Abstraction in Duplicate and Independent 58 (95) 3 (5)
13. Clinical Heterogeneity 8 (13) 53 (87)
14. Quantitative Data Synthesis
Principal Measure of Effect 52 (85) 9(15)
Method of Combining Data 40 (66) 21 (34)
Handling Missing Data 43 (70) 18 (30)
Statistical Heterogeneity 13 (21) 47 (77) 1 (2)
Rationale for Subgroups 7 (11) 45 (74) 9 (15)
Assessment of Publication Bias 0 (0) 61 (100)
Results
15. Trial flow 0 (0) 61 (100)
16. Study characteristics 53 (100) 0 (0)
17. Quantitative data synthesis
Agreement on selection 3 (5) 57 (93) 1 (2)
Agreement on validity 2 (4) 51 (94) 1 (2)
Summary result 50 (94) 1 (2) 2 (4)
Present data needed to calculate effect size 52 (98) 1 (2)
18. Discussion
Summarize key findings 60 (98) 1 (2)
Discuss internal and external validity 32 (53) 5 (8) 24 (39)
Discuss potential biases 3 (5) 53 (87) 5 (8)
Suggest future research 61 (100) 0 (0)
* Numbers (percentages)BMC Pediatrics 2009, 9:38 http://www.biomedcentral.com/1471-2431/9/38
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searched, and any additional sources of data. The majority
searched electronic databases, such as Medline and/or the
Cochrane Central Register of Controlled Trials (CEN-
TRAL) in the Cochrane Library, citation lists of included
studies, and conference proceedings. However, contact
with manufacturers (3%) and authors of included studies
(16%) to limit the chance of publication bias were inade-
quately reported. Only a small number of reviews
reported restrictions of the search to a certain year, lan-
guage, or to published studies only.
The selection criteria, validity assessment, and the princi-
ple measure of effect were clearly and adequately stated in
the methods section of the included reviews. However,
most of the reviews were deficient in adequate reporting
of clinical and statistical assessment of heterogeneity
(21%), and providing a rational for their planned sub-
group analysis (11%). None of the included reviews men-
tioned a priori plans of assessment of publication bias. The
statistical effect model planned a priori was reported in
most reviews; however, reviewers either chose a fixed
effect model (64%) or reported neither fixed nor random
models without adequate explanation of the rationale
and whether their choice would be altered by the subse-
quent heterogeneity assessment of the included stud-
ies[17].
Although the majority of the reviews reported a two
reviewer selection and data abstraction processes, only 3
(5%) reported agreement levels among the reviewers.
All reviews reported a detailed description of the included
and excluded studies, presented summarized results, and
the numbers needed to calculate the effect sizes. None of
the reviews presented a chart describing the trials flow.
A summary of the review's key findings and a suggestion
for a future research agenda were adequately reported in
the discussion section (98%); however, a discussion of the
internal and external validity issues and potential bias
(5%) in the review process and methods requires further
improvement.
Methodologic Quality (OQAQ items)
Table 3 presents a summary of OQAQ items scores (items
1–9) of the included reviews. Items that were adequately
reported include explicit mention of search methods,
comprehensiveness of search strategy, reporting of selec-
tion criteria of included studies, methods and appropri-
ateness of validity assessment criteria used, and a
conclusion that is supported by the analysis presented in
the review. Only 26% of included reviews explicitly
addressed how selection bias (particularly publication
bias) was avoided during the review process.
The overall quality scores (scale, 1–7; item 10) are pre-
sented in figure 1. CNRG systematic reviews scored a
mean of 4.5 (0.9), (95% CI of 4.27–4.77), which trans-
Table 3: Scores of included CNRG systematic reviews based on Overview Quality Assessment Questionnaire (OQAQ)
Response to Question *
OQAQ Question Yes Partially/Can't tell No
1. Search methods used to find evidence stated 61 (100) 0 (0) 0 (0)
2. Search for evidence reasonable comprehensive 52 (85) (0) 9 (15)
3. Criteria used for deciding which studies
to include reported
61 (100) 0 (0) 0 (0)
4. Bias in the selection of studies avoided 16 (26) 36 (59) 9 (15)
5. Criteria used for assessing validity of included studies reported 48 (79) 0 (0) 13 (21)
6. Validity of included studies assessed appropriately 47 (77) 13 (21) 1 (2)
7. Methods used to combine the findings of studies reported 37 (61) 9 (15) 15 (24)
8. Findings of studies combined appropriately 31 (59) 17 (32) 5 (9)
9. Conclusions made by authors supported by analysis 60 (98) 1 (2) 0 (0)
10. Overall quality score 4.5 (0.9), (95% CI: 4.27, 4.77)**
* Numbers (percentages)
** Mean (SD), 95% CI
Distribution of total OQAQ scores of CNRG systematic  reviews Figure 1
Distribution of total OQAQ scores of CNRG system-
atic reviews.BMC Pediatrics 2009, 9:38 http://www.biomedcentral.com/1471-2431/9/38
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lates into good quality with minor flaws of the included
reviews.
Effect of QUOROM statement publication on overall 
quality scores
A comparative assessment of the overall quality scores was
done based on the relationship to the QUOROM state-
ment publication (table 4). Reviews published post-
QUOROM had a significantly improved total OQAQ
score, with a mean difference of -1.03 (95% CI, -1.49 to -
0.56, p-value < 0.0001).
Discussion
Our review is the first report to assess the methodologic
and reporting quality of systematic reviews done in the
neonatal field; our findings should be quite reassuring to
neonatal practitioners. Overall, we found through the use
of available instruments that reviews published in CNRG
are generally of good quality; however, with minor flaws.
The Cochrane reviews in general included elements that
render them less prone to bias, such as a well-structured
format, description of inclusion and exclusion criteria,
and formal assessment of the trial's quality[10].
As mentioned above, we found that CNRG systematic
reviews scored high with regards to clearly stating their
objectives, comprehensiveness of search strategy, explicit
detailed inclusion criteria, formal quality assessment of
included trials, summarizing the key findings, and sugges-
tion of future research topics. However, room for
improvement still exists in some areas, such as the title,
abstract reporting, a priori plan for heterogeneity assess-
ment and how to handle heterogeneity in case it exists,
assessment of publication bias, reporting of agreement
among reviewers, documentation of trials flow, and dis-
cussion of possible biases in the review process.
As for most medical practitioners, health care profession-
als practicing in the neonatal field consider the results of
systematic reviews published in the Cochrane Library of
the highest level of evidence. Although the overall quality
of CNRG systematic reviews was judged to be good,
greater than one-third (41%) of the included reviews
scored 3–4 and were considered to have major flaws,
which poses an important question to the validity of the
recommendations. Therefore, readers must carefully and
critically appraise published reports prior to adopting a
recommendation as the basis for change in practice.
We found that the quality scores of included reviews sig-
nificantly improved after the publication of the
QUOROM statement. This observation is prone to many
biases and could simply represent improvement of
research methods by time trends or improvement in the
reviewer's methodological skills as they undertake more
reviews.
The final quality scores reported in this review are quite
comparable to the recently published review of quality of
systematic review in the Cochrane Musculoskeletal Group
(CMSG)[11] and higher than reported scores of system-
atic reviews published in anesthesia, critical care, emer-
gency medicine, and general surgery [3,18,19], which
reinforces the notion that Cochrane reviews, in general,
appear to have a high methodologic quality and "fre-
quently" updated[11].
Although we took all measures possible to enhance the
validity of our results, it is important to remind the reader
that our results are of an observational nature and are
prone to bias. An important observation we and the
authors of previous reports have noted [11,19] is the dif-
ficulty in applying the measurement tools (QUOROM
statement and OQAQ), hence these instruments were not
subjected to extensive validation testing hence these
instruments were not subjected to extensive validation
testing and lack clear and detailed guidance of their appli-
cation[19]. This is particularly important in applying the
overall quality score (Q10 in OQAQ), which we found to
be very subjective.
Conclusion
In conclusion, systematic reviews published in CNRG are
generally of good quality with minor flaws. However,
efforts should be made to improve abstract reporting,
handling of heterogeneity, assessment of publication bias,
and documentation of reviewer's agreement and trials
flow. Readers must continue assessing the quality of pub-
lished reports on an individual basis prior to implement-
ing their recommendations.
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